JNJ vs WFC: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Wells Fargo & Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
Wells Fargo & Company · Financial Services
$86.12
+20.4% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
WFC has more upside to fair value
(+20.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
WFC |
| Current Price |
$270.68 |
$86.12 |
| Fair Value Estimate |
$286.05 |
$103.68 |
| Upside to Fair Value |
+5.7%
|
+20.4%
|
| Market Cap |
$652.3B |
$260.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
20.2x
|
15.6x
|
| Price / Sales |
6.7x
|
2.0x
|
| Price / FCF |
35.3x
|
13.7x
|
| Revenue Growth YoY |
+6.6%
|
+11.3%
|
| Gross Margin |
67.9%
|
64.5%
|
| Operating Margin |
26.8%
|
21.2%
|
| Return on Equity |
25.7%
|
12.6%
|
| Dividend Yield |
1.95% |
2.15% |
| FCF Yield |
2.83%
|
7.3%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Wells Fargo is a diversified U.S. bank with roughly 197,000 employees operating four segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The business quality is solid but not exceptional: trailing return on equity is 12.6%, TTM net margin is 17.5%, and revenue grew 11.3% year over year in the most recent quarter while…
Accumulation Zones
| Metric |
JNJ |
WFC |
| Zone Low |
$214.54 |
$77.76 |
| Zone High |
$243.14 |
$88.13 |
| In Buy Zone? |
No
|
Yes
|